Racial-Ethnic Disparities of Buprenorphine and Vivitrol Receipt in Medicaid

Racial-Ethnic Disparities of Buprenorphine and Vivitrol Receipt in Medicaid, in American Journal of Preventive Medicine

key takeaway: "Non-Hispanic Black people, non-Hispanic American Indian or Alaskan Native/Asian/Hawaiian/Pacific Islander people, and Hispanic people had 42%, 12%, and 22% lower odds of buprenorphine receipt and 47%, 12%, and 20% lower odds of Vivitrol receipt, respectively, than non-Hispanic White people, controlling for clinical and demographic patient variables."